EQT Healthcare Growth Agrees to Acquire Majority Stake in Europa Biosite

EQT to Acquire Majority Stake in Universidad Europea from Permira

April 8, 2024

Education

EQT Infrastructure VI has agreed to acquire a majority position in Universidad Europea from Permira, which will retain a significant minority stake. EQT plans to invest in the university's campuses and digital capabilities to expand its online and hybrid learning proposition and support geographic expansion; the company operates 12 campuses across Spain and Portugal with 3,400 employees and 54,000 students.

Nordic BioSite Group (Europa Biosite) Acquires LubioScience

September 11, 2023

Healthcare Services

Nordic BioSite Group — which is rebranding to Europa Biosite — has acquired Swiss life-science distributor LubioScience. The deal expands the group's European footprint into Switzerland; financial terms were not disclosed and LubioScience's founders will remain with the business.

Adelis Equity Partners Becomes Majority Owner of Nordic BioSite Group

May 28, 2021

Healthcare Services

Adelis Equity Partners has acquired a majority stake in Nordic BioSite Group to accelerate the group's growth and pan‑European expansion of its life‑science research and diagnostics distribution platform. Tellacq Partners, together with the founders and management team, had built the group (including Nordic Biosite AB, Sanbio BV and Biomol GmbH); the parties did not disclose the purchase price.

Discovery Life Sciences Acquires East West Biopharma

November 9, 2020

Healthcare Services

Discovery Life Sciences acquired East West Biopharma, a European human biospecimen contract research organization with a large biocollection network in Ukraine. The deal expands Discovery’s biospecimen collection and clinical site footprint across Europe, strengthening its global position as a leading provider of biospecimen and related scientific services.

EQT Public Value Invests in BioGaia AB

November 2, 2020

Biotechnology

EQT Public Value, an EQT Partners fund, has committed to acquire 1,625,000 B shares in Swedish probiotic company BioGaia AB via a directed share issue for SEK 650 million, subject to approval at an extraordinary general meeting. The investment is a minority growth-capital commitment intended to support BioGaia's continued global expansion by providing access to EQT's healthcare expertise, advisory network and in-house digital and sustainability teams.

Equistone Partners Europe Acquires Majority Stake in Omnicare

August 14, 2019

Pharmaceuticals

Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.